First Time Loading...

CloudMD Software & Services Inc
XTSX:DOC

Watchlist Manager
CloudMD Software & Services Inc Logo
CloudMD Software & Services Inc
XTSX:DOC
Watchlist
Price: 0.045 CAD -10% Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

DOC Price Targets Summary
CloudMD Software & Services Inc

Wall Street analysts forecast DOC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOC is 0.51 CAD with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.

DOC Lowest Forecast
Wall Street Target
0.505 CAD
1 022% Upside
DOC Average Forecast
Wall Street Target
0.51 CAD
1 033% Upside
DOC Highest Forecast
Wall Street Target
0.525 CAD
1 067% Upside
Lowest
Price Target
0.505 CAD
1 022% Upside
Average
Price Target
0.51 CAD
1 033% Upside
Highest
Price Target
0.525 CAD
1 067% Upside
CloudMD Software & Services Inc Competitors:
Price Targets
H
AIDX
Healwell Al Inc
9% Downside
DVA
DaVita Inc
0% Upside
OPCH
Option Care Health Inc
35% Upside
MGP
Medica Group PLC
2% Downside
H
AIDX
Healwell Al Inc
9% Downside
DVA
DaVita Inc
0% Upside
OPCH
Option Care Health Inc
35% Upside
MGP
Medica Group PLC
2% Downside
CCRN
Cross Country Healthcare Inc
17% Upside
FLGT
Fulgent Genetics Inc
27% Upside
600763
Topchoice Medical Co Inc
44% Upside
SHLTN
SHL Telemedicine Ltd
163% Upside

Revenue
Forecast

Revenue Estimate
CloudMD Software & Services Inc

For the last 6 years the compound annual growth rate for CloudMD Software & Services Inc's revenue is 196%. The projected CAGR for the next 3 years is 8%.

196%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CloudMD Software & Services Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CloudMD Software & Services Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

See Also

Summary
DOC intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOC stock valuation using valuation multiples.
Wall Street Estimates
DOC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DOC's stock price target?
Price Target
0.51 CAD

According to Wall Street analysts, the average 1-year price target for DOC is 0.51 CAD with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.

What is CloudMD Software & Services Inc's Revenue forecast?
Projected CAGR
8%

For the last 6 years the compound annual growth rate for CloudMD Software & Services Inc's revenue is 196%. The projected CAGR for the next 3 years is 8%.

ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.